Add-On Payments for New Medical Services and Technologies Paid Under the Inpatient Prospective Payment System (IPPS) (CMS-10638)

ICR 202309-0938-008

OMB: 0938-1347

Federal Form Document

Forms and Documents
IC Document Collections
IC ID
Document
Title
Status
262237 New
227314 Modified
ICR Details
0938-1347 202309-0938-008
Received in OIRA 202204-0938-009
HHS/CMS CM-FFS
Add-On Payments for New Medical Services and Technologies Paid Under the Inpatient Prospective Payment System (IPPS) (CMS-10638)
Revision of a currently approved collection   No
Regular 09/20/2023
  Requested Previously Approved
36 Months From Approved 11/30/2023
62 62
1,655 1,655
0 0

Sections 1886(d) (5) (K) and (L) of the Act establish a process of identifying and ensuring adequate payment for new medical services and technologies (sometimes collectively referred to in this section as ‘‘new technologies’’) under the IPPS. Section1886(d)(5)(K)(vi) of the Act specifies that a medical service or technology will be considered new if it meets criteria established by the Secretary after notice and opportunity for public comment. Section 1886(d)(5)(K)(ii)(I) of the Act specifies that a new medical service or technology may be considered for new technology add-on payment if, ‘‘based on the estimated costs incurred with respect to discharges involving such service or technology, the DRG prospective payment rate otherwise applicable to such discharges under this subsection is inadequate.’’ The regulations at 42 CFR 412.87 implement these provisions and specify three criteria for a new medical service or technology to receive the additional payment: (1) The medical service or technology must be new; (2) the medical service or technology must be costly such that the DRG rate otherwise applicable to discharges involving the medical service or technology is determined to be inadequate; and (3) the service or technology must demonstrate a substantial clinical improvement over existing services or technologies.

US Code: 42 USC 1395ww Name of Law: Add-On Payments for New Medical Services and Technologies Policy
  
None

Not associated with rulemaking

  88 FR 41632 06/27/2023
88 FR 63579 09/15/2023
No

2
IC Title Form No. Form Name
Alternative NTAP Pathway CMS-10638 New Technology Application
Traditional NTAP Pathway CMS-10638 New Technology Application

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 62 62 0 0 0 0
Annual Time Burden (Hours) 1,655 1,655 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
The total hourly burden for all the applicants to fill out and answer questions for their applications will remain the same at 1,655 hours. This includes a total of 1,280 hours for applications on the traditional pathway and 375 hours for those in the alternative pathway. For FY 2025, we are updating the NTAP MEARIS™ application to further simplify or clarify existing application questions, including: a) reorganizing the Coding, Cost, and Volume sections of the application to improve flow, b) simplifying the FDA section questions and revising language for these questions to reflect policy changes effective for FY 2025, c) simplifying the way applicants can include codes and MS-DRGs, and d) adding additional explanatory notes in multiple sections of the application to improve understanding of the question. These changes will not result in any net increase in burden for applicants.

$1,351,344
No
    No
    No
No
No
No
No
Stephan McKenzie 410 786-1943 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
09/20/2023


© 2024 OMB.report | Privacy Policy